These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 37855085)

  • 21. High-resolution three-dimensional NMR structure of the
    Kerkour A; Marquevielle J; Ivashchenko S; Yatsunyk LA; Mergny JL; Salgado GF
    J Biol Chem; 2017 May; 292(19):8082-8091. PubMed ID: 28330874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of G-Quadruplex-Binding Plant Secondary Metabolites on
    Zenkov RG; Kirsanov KI; Ogloblina AM; Vlasova OA; Naberezhnov DS; Karpechenko NY; Fetisov TI; Lesovaya EA; Belitsky GA; Dolinnaya NG; Yakubovskaya MG
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions.
    Qin Y; Hurley LH
    Biochimie; 2008 Aug; 90(8):1149-71. PubMed ID: 18355457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural Alkaloids and Heterocycles as G-Quadruplex Ligands and Potential Anticancer Agents.
    Che T; Wang YQ; Huang ZL; Tan JH; Huang ZS; Chen SB
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29473874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging Role of G-quadruplex DNA as Target in Anticancer Therapy.
    Cimino-Reale G; Zaffaroni N; Folini M
    Curr Pharm Des; 2016; 22(44):6612-6624. PubMed ID: 27587203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural Polymorphism of Guanine Quadruplex-Containing Regions in Human Promoters.
    Hennecker C; Yamout L; Zhang C; Zhao C; Hiraki D; Moitessier N; Mittermaier A
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand-induced native G-quadruplex stabilization impairs transcription initiation.
    Li C; Wang H; Yin Z; Fang P; Xiao R; Xiang Y; Wang W; Li Q; Huang B; Huang J; Liang K
    Genome Res; 2021 Sep; 31(9):1546-1560. PubMed ID: 34400476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands.
    Jain AK; Bhattacharya S
    Bioconjug Chem; 2011 Dec; 22(12):2355-68. PubMed ID: 22074555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G-Quadruplex-Binding Proteins: Promising Targets for Drug Design.
    Shu H; Zhang R; Xiao K; Yang J; Sun X
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crosstalk between G-Quadruplexes and Dnmt3a-Mediated Methylation of the
    Sergeev AV; Loiko AG; Genatullina AI; Petrov AS; Kubareva EA; Dolinnaya NG; Gromova ES
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenanthroline polyazamacrocycles as G-quadruplex DNA binders.
    Carvalho J; Quintela T; Gueddouda NM; Bourdoncle A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
    Org Biomol Chem; 2018 Apr; 16(15):2776-2786. PubMed ID: 29611599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide analysis of regulatory G-quadruplexes affecting gene expression in human cytomegalovirus.
    Ravichandran S; Kim YE; Bansal V; Ghosh A; Hur J; Subramani VK; Pradhan S; Lee MK; Kim KK; Ahn JH
    PLoS Pathog; 2018 Sep; 14(9):e1007334. PubMed ID: 30265731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unlocking G-Quadruplexes as Antiviral Targets.
    Abiri A; Lavigne M; Rezaei M; Nikzad S; Zare P; Mergny JL; Rahimi HR
    Pharmacol Rev; 2021 Jul; 73(3):897-923. PubMed ID: 34045305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA G-quadruplex binders: a patent review.
    Yan Y; Tan J; Ou T; Huang Z; Gu L
    Expert Opin Ther Pat; 2013 Nov; 23(11):1495-509. PubMed ID: 23972147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting of Telomeric Repeat-Containing RNA G-Quadruplexes: From Screening to Biophysical and Biological Characterization of a New Hit Compound.
    Marzano S; Pagano B; Iaccarino N; Di Porzio A; De Tito S; Vertecchi E; Salvati E; Randazzo A; Amato J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why to target G-quadruplexes using peptides: Next-generation G4-interacting ligands.
    Sharma T; Kundu N; Kaur S; Shankaraswamy J; Saxena S
    J Pept Sci; 2023 Oct; 29(10):e3491. PubMed ID: 37009771
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    D'Aria F; Pagano B; Petraccone L; Giancola C
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G-quadruplexes: a promising target for cancer therapy.
    Kosiol N; Juranek S; Brossart P; Heine A; Paeschke K
    Mol Cancer; 2021 Feb; 20(1):40. PubMed ID: 33632214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. G-quadruplexes and G-quadruplex ligands: targets and tools in antiviral therapy.
    Ruggiero E; Richter SN
    Nucleic Acids Res; 2018 Apr; 46(7):3270-3283. PubMed ID: 29554280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural insights into G-quadruplexes: towards new anticancer drugs.
    Yang D; Okamoto K
    Future Med Chem; 2010 Apr; 2(4):619-46. PubMed ID: 20563318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.